AI assistant
Sending…
Cardiff Oncology, Inc. — Director's Dealing 2020
May 18, 2020
33967_dirs_2020-05-18_9a256a7f-61db-4547-8970-a55e773f3bc2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardiff Oncology, Inc. (CRDF)
CIK: 0001213037
Period of Report: 2020-05-14
Reporting Person: White Lale (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-14 | Common Stock | P | 69930 | $1.43 | Acquired | 69930 | Indirect |
More from Cardiff Oncology, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Feb 25
Regulatory Filings
2026
Feb 24
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 9